Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria

No abstract is available for this paper.

• Publication year

  2000

• Venue

  British Journal of Dermatology

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2133.2000.03664.xPMID 10951147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria

  1999cited by this paper
• Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria.

  1998cited by this paper
• Comparative studies of functional and binding assays for IgG anti-FcϵRIα (α-subunit) in chronic urticaria ☆ ☆☆ ★ ★★

  1998cited by this paper
• A randomized, double‐blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis

  1998cited by this paper
• Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.

  1998cited by this paper
• Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticaria

  1997cited by this paper
• Assessment of autoimmunity in patients with chronic urticaria.

  1997cited by this paper
• Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria.

  1996cited by this paper
• Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.

  1996cited by this paper
• Evidence Based Medicine—How to Practice and Teach EBM

  1996cited by this paper
• Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse.

  1995cited by this paper
• Mechanisms of inhibition by cyclosporin A on pulmonary leukocyte accumulation.

  1994cited by this paper
• Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.

  1993cited by this paper
• Treatment of severe, chronic urticaria with cyclosporin A

  1993cited by this paper
• Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.

  1992cited by this paper
• Anti-inflammatory effect of cyclosporin A on human skin mast cells.

  1992cited by this paper
• Cyclosporin A in atopic dermatitis: therapeutic resonse is disociated form effects on allergic reactons

  1991cited by this paper
• Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.

  1990cited by this paper
• Covariate imbalance and random allocation in clinical trials.

  1989cited by this paper
• Statistical Methods for Rates and Proportions, 2nd ed

  1981cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper

• The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

  2026cites this paper
• Advancements In Novel Therapeutics For Chronic Spontaneous Urticaria.

  2025cites this paper
• Urticaires

  2025cites this paper
• Management of chronic urticaria: Treatment options when omalizumab fails.

  2025cites this paper
• Noninferiority Trial: Sample Size Calculation and Its Interpretation in Health Research

  2025cites this paper
• Narrow Band Ultraviolet B Phototherapy Versus Oral Cyclosporine in the Treatment of Chronic Urticaria

  2025cites this paper
• Clinical and quality of life improvement after bilastine treatment among patients with autoimmune chronic spontaneous urticaria

  2025cites this paper
• Cyclosporine in dermatology: Evidence-based review with a special focus on recent updates

  2025cites this paper
• Think again about cyclosporine for chronic spontaneous urticaria.

  2025cites this paper
• Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.

  2025cites this paper
• Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis.

  2025cites this paper
• Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.

  2025cites this paper
• Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response

  2025cites this paper
• Urticaria

  2024cites this paper
• Patient and physician perspectives on disease burden in chronic spontaneous urticaria: A real-world US survey.

  2024cites this paper
• Quantifying patient preferences for treatments for refractory chronic spontaneous urticaria

  2024cites this paper
• Międzynarodowe wytyczne EAACI/GA2LEN/EuroGuiDerm/APAAACI dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki

  2024cites this paper
• Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

  2024cites this paper
• The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  2024cites this paper
• Disease modification in chronic spontaneous urticaria

  2024cites this paper
• Research hotspots in urticaria: A bibliometric study of the top 100 most cited articles

  2024cites this paper
• Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets

  2024cites this paper
• Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment.

  2024cites this paper
• Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab

  2024cites this paper
• Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment.

  2023cites this paper
• Patient-reported outcome measures for urticaria and angioedema.

  2023cites this paper
• Comparative effectiveness and safety of drug therapy for chronic urticaria: a network meta-analysis and risk-benefit assessment.

  2023cites this paper
• Biomarkers of chronic spontaneous urticaria

  2023cites this paper
• Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences

  2023cites this paper
• Positive basophil tests are linked to high disease activity and other features of autoimmune chronic spontaneous urticaria: A systematic review.

  2023cites this paper
• Urticaria: A Narrative Overview of Differential Diagnosis

  2023cites this paper
• Modern approaches to the treatment of chronic urticaria

  2023cites this paper
• Modern Approaches to the Management of Patients with Urticaria

  2023cites this paper
• S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline

  2023cites this paper
• Prise en charge de l’urticaire chronique spontanée : recommandations françaises

  2023cites this paper
• THE ROLE OF ADJUVANT THERAPY IN THE MANAGEMENT OF CHRONIC URTICARIA.

  2023cites this paper
• Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.

  2023cites this paper
• S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie

  2023cites this paper
• Efficacy and safety of medications for antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis

  2022cites this paper
• Biologics for chronic spontaneous urticaria: toward a personalized treatment

  2022cites this paper
• [Autoimmunity in chronic urticaria. A historical and current perspective].

  2022cites this paper
• Chronic spontaneous urticaria guidelines: What is new?

  2022cites this paper
• Effectiveness and Safety of Immunosuppressants and Biological Therapy for Chronic Spontaneous Urticaria: A Network Meta-Analysis

  2022cites this paper
• Urticaria

  2022cites this paper
• Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring.

  2022cites this paper
• Urticaria

  2022cites this paper
• Management of Allergic Skin Disorders in Pregnancy.

  2022cites this paper
• Autoimmune chronic spontaneous urticaria.

  2022cites this paper
• Omalizumabe versus ciclosporina‐A para o tratamento da urticária crônica espontânea: podemos definir endótipos com melhor resposta?

  2022cites this paper
• Reporte de dos casos infrecuentes de urticaria inducible en niños y un caso de urticaria por presión en mujer adulta durante la actividad sexual

  2022cites this paper
• Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

  2022cites this paper
• Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination

  2022cites this paper
• Immunological signature of chronic spontaneous urticaria (Review)

  2022cites this paper
• Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

  2022cites this paper
• Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder

  2021cites this paper
• Other Interventions for Chronic Urticaria

  2021cites this paper
• Cyclosporine

  2021cites this paper
• Ciclosporin: An Old Ally in the Treatment of Chronic Spontaneous Urticaria.

  2021cites this paper
• What Basophil Testing Tells Us About CSU Patients – Results of the CORSA Study

  2021cites this paper
• Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management

  2021cites this paper
• The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

  2021cites this paper
• The Role of Anti-IgE Antibodies in Urticaria

  2021cites this paper
• Urticaria Therapy and Management. Looking Forward

  2021cites this paper
• The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations☆

  2021cites this paper
• The diagnostic workup in chronic spontaneous urticaria - what to test and why.

  2021cites this paper
• Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines

  2021cites this paper
• What's New in the Treatment of Urticaria and Angioedema.

  2021cites this paper
• Chronic spontaneous urticaria: An updated comprehensive review of etiology, pathogenesis and management

  2021cites this paper
• Ciclosporin: An Old Ally in the Treatment of Chronic Spontaneous Urticaria.

  2021cites this paper
• A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

  2021cites this paper
• Biomarkers of chronic spontaneous urticaria and their clinical implications

  2021cites this paper
• Aetiopathogenesis of Urticaria

  2021cites this paper
• Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Network Meta-analysis.

  2021cites this paper
• Predictors of treatment response in chronic spontaneous urticaria

  2021cites this paper
• Mecanismos inmunitarios en la patogénesis de la urticaria crónica espontánea

  2021cites this paper
• Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration

  2020cites this paper
• Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics

  2020cites this paper
• Urticaria

  2020cites this paper
• The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria

  2020cites this paper
• The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria

  2020cites this paper
• A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement From Andalusia, Spain

  2020cites this paper
• A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain.

  2020cites this paper
• Omalizumab response correlates with reduced IFN‐γ‐, IL‐10‐ and IL‐31‐secreting cells in chronic spontaneous urticaria

  2020cites this paper
• Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020

  2020cites this paper
• Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment

  2020cites this paper
• Management of Severe Chronic Urticaria: Current and Future Therapies

  2020cites this paper
• Urticaires

  2020cites this paper
• Managing Chronic Urticaria: Quo Vadis?

  2020cites this paper
• Efficacy of Injection Histoglob in Treatment of Chronic Urticaria-A Prospective Study

  2019cites this paper
• Itch

  2019cites this paper
• Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.

  2019cites this paper
• Urticaria

  2019cites this paper
• British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

  2019cites this paper
• Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria.

  2019cites this paper
• Traitement de l’urticaire chronique par omalizumab : données en vie réelle

  2019cites this paper
• Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review

  2019cites this paper
• Treatment of urticaria: a clinical and mechanistic approach.

  2019cites this paper
• Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications

  2019cites this paper
• Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study☆

  2019cites this paper
• Another look at cyclosporine for treating antihistamine-resistant chronic spontaneous urticaria.

  2019cites this paper